
Authors
As companies face increasing pressure to decarbonize their operations and investments, their boards are increasingly making the management of climate-related risks and opportunities a strategic priority. Strong leadership and governance in this area are critical.
Achieving net zero and other emissions reduction targets1 requires charting a course through technological and regulatory uncertainty, requiring a multi-faceted understanding of the science of carbon emissions, operational considerations, financial impacts, regulatory and disclosure requirements, and stakeholder priorities. The breadth of these issues makes it difficult for anyone to become fluent across all of them. Yet given the implications of climate change on their organizations, many directors and senior executives are quickly expanding their competencies to meet the challenge.
The transition to a low carbon economy is quickly changing the regulatory landscape in which companies operate. Various jurisdictions around the world have started to adopt net zero legislation and set national emissions reduction targets. In July 2021, the European Climate Law was entered into force, setting new binding EU-wide targets to reduce GHG emissions 55% below 1990 levels by 2030, and to achieve net zero emissions by 2050. Canada’s net zero Emissions Accountability Act enshrines the government’s commitment to achieve net zero by 2050 and provides a framework of accountability and transparency to deliver on that pledge. Certain U.S. states have passed similar legislation. For example, Massachusetts passed a new climate law last year with binding emission reduction targets of 50% below 1990 levels by 2030 and 75% below 1990 levels by 2040, as well as net zero emissions by 2050. These commitments are increasingly driving the development of specific policies and regulations intended to regulate and incentivize domestic GHG reductions—including carbon pricing regimes that will become significantly more stringent in the coming years.
Securities regulators are also developing rules for the disclosure by public companies of climate change risks and opportunities. The U.S. Securities and Exchange Commission (SEC) and the Canadian Securities Administrators (CSA) have each proposed rules that, if adopted, would require reporting companies to report climate-related information in their public filings. Both proposals are modelled in part on the recommendations of the Taskforce on Climate-Related Financial Disclosures (TCFD). Climate change disclosure is increasingly a focus of other regulators as well, including the Canadian Office of the Superintendent of Financial Institutions (OSFI), which recently closed consultation on draft guidelines that would provide federally regulated financial institutions with a framework for managing climate-related risk and require them to make climate-related financial disclosures.
These are only some examples, and more regulation is expected. Yet there remains significant uncertainty around the timing and details of future rules, particularly as the current markets are pressured by energy security and scarcity issues. Climate change also remains a political issue in many jurisdictions, and proposed carbon price increases will be put to the ballot box in coming years.
Boards are confronting this rapid change and uncertainty as they guide their organizations through the energy transition. To do so effectively, the following considerations will be key:
Ensuring training and support. Boards must evaluate their composition to determine whether they have the appropriate skills and expertise internally to be properly informed and to oversee the organization’s climate strategy. In many cases, boards may need to invest in education and provide regular, dedicated agenda time for these complex issues. They may also need external expert advice not only for education and strategic advice, but also to help evaluate the efficacy of management’s specific proposals, action plans and progress.
Engaging with stakeholders. In Canada, directors and officers are obliged to make decisions in the “best interests of the Corporation” taking into account the interests of different stakeholders. Not surprisingly, stakeholder sentiment on climate change issues remains dynamic, with different stakeholders expressing different and at times competing priorities. Management and boards should try to anticipate emerging issues and trends and be in “listening mode” to understand the views of different constituencies and build strong relationships over time. Board engagement with stakeholders on these topics should happen early and regularly, not just when problems emerge and engagement is forced. It is important that the board, not just management, can demonstrate that it is actively engaged and understands stakeholders’ viewpoints and concerns, accommodating where possible and explaining where there are diverging approaches.
Implementing governance structures. Given the complexity and long timelines of many decarbonization commitments, it will also be important to establish well-functioning governance structures to oversee the implementation of climate transition plans. There is no one-size-fits-all governance structure that will work for every organization. Rather, each organization should tailor its reporting structure and division of responsibilities to the nature of its business and board composition. Each board should consider the best use of its own and management’s resources and competencies to address the development and oversight for their organization’s climate plan. In some cases, the board may define executive functions and determine whether separate committees are responsible for certain aspects and report to the board for debate and decision-making. In others, the board may determine objectives and then delegate certain aspects to committees for ongoing responsibility. Many organizations now have sustainability committees, at the management level, the board level, or both.
Defining roles and responsibilities. Under any approach, the responsibilities and reporting structures need to be embedded and defined in the board and committee charters and properly prioritized and integrated across the organization, not siloed to separate functions. The full board is ultimately responsible to develop and evaluate their net zero strategy, then determine the governance structure and provide oversight to ensure progress for the strategy. Once the management and board structures are defined, it is important that the management and committees are aligned and coordinated in their functions and reporting to the board, and that adaptations are made as needed over time.
Integrating climate change considerations throughout the organization. To effectively implement a climate transition plan, an organization must embrace the plan as central to its business. Boards will play a key role in kickstarting and overseeing this integration. Board members must be actively engaged with their company’s climate transition plan, recognizing that these plans will require significant innovation and coordination across multiple functional units and skill sets. This is especially important when implementing an organization’s climate transition plan, as discussed further below.
Learn how to lead your organization in the race to net zero. Visit our series.
There has been significant pressure in recent years for organizations to announce net zero and other emissions reduction targets. The UNFCCC’s Race to Zero initiative now reports over 7,000 companies with a net zero pledge2. According to the online net zero tracker, of the world’s 2,000 largest publicly-traded companies by revenue, 790 have announced a net zero or similar commitments3. However, net zero is no longer just the purview of the world’s largest public companies and institutional investors; mid-market and small cap companies, including private companies, are increasingly turning their minds to target setting.
That said, while many companies have now announced targets, far fewer have disclosed a plan for how they intend to meet those targets4. And those plans that have been published vary considerably in their operational scope, emissions coverage, and implementation timelines. Amid increasing litigation and shareholder activism5, organizations will be expected to develop more concrete plans for how targets are going to be met, and stakeholders will likely continue to increase the pressure for accountability for those targets and action plans.
Given this state of play, it will be important for boards to focus not only on setting targets, but also on ensuring the organization has in a plan in place that is supported by adequate resources to achieve those targets—even if that plan may evolve and become more detailed over time. A well-considered implementation plan will help ensure targets are credible not only to investors and external stakeholders, but also within the organization to the employees that are tasked with achieving those targets. Boards must therefore ensure management has the time and resources to “do their homework” and gather and assess the data and information to set meaningful short-, medium- and long-term targets that can be implemented, monitored, measured, and verified.
At the same time, given the imperative of mitigating climate change, organizations cannot afford to wait for perfection before acting. The objectives of a climate transition plan may need to change over time in response to scientific, technological, regulatory, and economic developments. And it may take time to resolve data collection challenges. For example, while many organizations have an accurate picture of their Scope 1 emissions, they may face challenges in obtaining Scope 2 or 3 emissions data, given that this information often requires input from third parties or public resources6. In these cases, it may be necessary to recognize the limitations of the data, make reasonable assumptions and ensure those limitations and assumptions are transparently stated alongside an organization’s targets or performance metrics. As organizations make more detailed disclosure (whether voluntary or mandatory) regarding their targets and progress, boards will need to ensure organizations have established proper disclosure practices under a consistent and recognized framework, with tailored qualifiers and cautionary statements.
As companies move beyond target setting toward implementation and accountability, they will increasingly face investor and stakeholder pressure—and risk shareholder proposals and litigation—if their climate transition goals are not being met. This is a serious consideration for boards given that many climate transition plans are, in effect, plans for major organizational change as companies modify, to varying degrees, how they do business. A company facing such a significant transition must fully embrace its climate strategy as an organization-wide priority. With a broadly integrated mindset, the climate strategy should be a driving force for decision-making throughout the existing operations and business, in financial decisions, in growth strategies and M&A transactions, in the advancement of new projects and technologies, and in evaluating partners and others in the supply chain. For carbon-intensive businesses, innovation and investment will be required at many levels of the organization over a long-time horizon, and the board must ensure that the investments and timelines for new staff, R&D, technology and operational changes, and resources and budgets are aligned.
In addition, many commentators are suggesting that organizations should reflect their success in achieving climate goals in their compensation criteria. Organizations adopting this approach may need to consider how to select climate-focused performance indicators and scorecards that can be measured and assessed on a consistent basis in annual compensation decisions over time. They may also need to rebalance other performance indicators. Boards should adopt the same rigour in assessing these criteria as they do with other metrics, and should consider how these criteria and compensation philosophies will be disclosed in proxy materials.
In exercising their duties, boards will need to expand their expertise and think holistically about their organization’s needs while staying flexible in light of the changing dynamics of addressing climate change. With the world working in concert to take on this common and global challenge, companies will want to be agile and responsive to change on the road to net zero in order to remain competitive.
Le mois dernier, le Canada a publié sa première Stratégie industrielle de défense (la Stratégie), qui souligne l’engagement du Canada à développer une base industrielle de défense solide et à stimuler la croissance économique. Ces efforts pourraient aussi comprendre le renforcement de l’état de préparation à la biodéfense et aux contre-mesures médicales, ce qui pourrait constituer des débouchés pour le secteur canadien des sciences de la vie en raison de l’importance accordée aux capacités nationales en ce sens et de la nécessité d’atténuer les risques d’urgences sanitaires.
Comme indiqué dans les bulletins précédents, le quatrième pilier de la Stratégie est axé sur la « sécurisation des chaînes d’approvisionnement pour les intrants et les biens clés » par le renforcement de la production nationale et le stockage de ressources. L’accent est mis tout particulièrement sur les contre-mesures médicales, en précisant que nos « alliés ont établi un lien explicite entre l’état de préparation à la biodéfense et aux contre-mesures médicales et leur sécurité économique et nationale, en élaborant de nouvelles stratégies et de nouveaux mécanismes pour faire progresser ces travaux ». Les contre-mesures médicales désignent divers produits réglementés pouvant être utilisés pour protéger la population lors d’une situation d’urgence de grande ampleur, comme l’éclosion d’une maladie ou une attaque impliquant des armes chimiques, biologiques ou nucléaires. Il peut s’agir de vaccins, de médicaments thérapeutiques et produits biologiques, de dispositifs de tests diagnostiques, des équipements de protection individuelle ou industrielle, et d’autres dispositifs médicaux. Les contre-mesures médicales sont essentielles à la réduction et à l’atténuation des dommages lors d’une urgence de santé publique.
Pendant et après la pandémie de COVID-19, le Canada a mis en place plusieurs nouvelles voies réglementaires comme mécanismes d’accélération des approbations de produits médicaux, ce qui pourrait offrir au gouvernement des options pour déployer des contre-mesures médicales afin de faire face aux risques pour la santé publique. Au début de la pandémie, Santé Canada a émis diverses ordonnances provisoires pour permettre l’importation et la vente de médicaments et de dispositifs médicaux qui n’avaient pas eu l’approbation des voies réglementaires traditionnelles. Or, Santé Canada a plutôt fait confiance aux voies d’approbation réglementaire et de l’exemption de certaines exigences en homologation de produits des pays impliqués dans la transaction. Beaucoup de ces règles provisoires ont depuis été officiellement intégrées à la réglementation en vertu de la Loi sur les aliments et drogues et ont été appliquées bien après la COVID-19. Conformément au Règlement sur les aliments et drogues, Santé Canada tient à jour la Liste des maladies qui menacent la santé publique et utilisera une procédure d’autorisation modifiée pour les médicaments d’urgence de santé publique pouvant traiter les affections figurant sur la liste. De même, le Règlement sur les instruments médicaux a établi une liste d’instruments médicaux répondant à un besoin urgent de santé publique, ce qui permet à Santé Canada d’autoriser la commercialisation de ces instruments de manière accélérée. Ces outils réglementaires sont utilisés automatiquement quand une situation médicale présente un grand risque pour la santé publique au Canada et nécessite une action immédiate pour contrer ce risque.
La stratégie prévoit que le Canada adoptera une approche proactive en matière de planification en amont des crises sanitaires. Le gouvernement entend s’assurer que les produits médicaux sont déjà disponibles au Canada afin qu’ils puissent être distribués rapidement en cas d’urgence. D’autres modifications récentes au Règlement sur les aliments et drogues permettent de prépositionner au Canada tous les médicaments d’urgence en santé publique, ce qui signifie qu’ils peuvent être importés dans des installations d’entreposage canadiennes avant que leur mise sur le marché n’ait été autorisée. La Stratégie s’appuie sur ces fondements, en faisant référence à l’organisme existant Préparation aux crises sanitaires Canada (PCSC), un organisme opérationnel spécial au sein d’Innovation, Sciences et Développement économique Canada (ISDE), et à un nouveau Fonds des sciences de la vie, lesquels « collaborent avec des partenaires internationaux et de soutenir l’élaboration et la production de contre-mesures médicales ». PCSC supervise la Stratégie en matière de biofabrication et de sciences de la vie du Canada, qui vise à développer un secteur national des sciences de la vie fort et compétitif doté de capacités de biofabrication de pointe, en mettant l’accent sur la capacité à se préparer et à faire face aux futures priorités et crises sanitaires. Dans cette optique, il y aura des occasions pour les fabricants de nouer des collaborations de recherche et des accords commerciaux ou d’approvisionnement liés aux contre-mesures médicales financées par des programmes fédéraux.
Étroitement lié aux capacités nationales, le pilier III de la stratégie implique « Investissement ciblé pour renforcer un secteur canadien de la défense novateur », avec la promesse que le gouvernement fédéral « soutiendr[a] la recherche et le développement, protéger[a] la propriété intellectuelle, soutiendr[a] les petites et moyennes entreprises, investir[a] dans les compétences et la formation, et encourager[a] les exportations afin de créer un secteur de la défense agile et concurrentiel à l’échelle mondiale ». La nécessité de favoriser le développement de la propriété intellectuelle (PI) et la conservation des droits du Canada est mentionnée à plusieurs reprises dans la Stratégie. Par exemple, la Stratégie prévoit l’établissement de partenariats officiels avec l’industrie canadienne qui « [assureront] la propriété et le contrôle nationaux de la propriété intellectuelle (PI) et des capacités essentielles. » La Stratégie reconnaît l’immense talent des établissements canadiens et la précieuse recherche qui y est menée actuellement et qui est déjà financée par des subventions de recherche d’organismes tels que le Conseil de recherches en sciences naturelles et en génie et les Instituts de recherche en santé du Canada, et fait aussi référence à l’engagement de 1,6 milliard de dollars pour de nouveaux fonds de recherche dans le budget de 2025. Cette prise de conscience de la nécessité de promouvoir et de soutenir l’innovation au Canada laisse présager des possibilités de financement, notamment dans les domaines où le Canada accuse un retard en matière de production nationale et où des engagements d’investissement et de fabrication au Canada peuvent être pris.
Dans les prochains mois, nous prévoyons que le gouvernement du Canada publiera d’autres directives et des mesures de suivi. L’équipe de défense des conservateurs poursuivra sa couverture de perspectives sur la défense au Canada en publiant une analyse supplémentaire pour donner des précisions sur l’incidence de la Stratégie sur de multiples secteurs.